Addressing Barriers to EoE Diagnosis and Treatment: The Role of Updated Guidelines and Novel Therapies

Activity Overview

Eosinophilic esophagitis (EoE) is a rare, debilitating chronic inflammatory disorder. Unfortunately, diagnostic delay is common and current management approaches do not fully address EoE symptoms or provide endoscopic and histologic resolution. However, several pathophysiologic pathways have been described and targeted therapies are under study for the treatment of EoE.

Join us for this live event to hear a multidisciplinary panel of experts and a patient with EoE discuss the diagnosis and management of this disorder, as well as pathophysiologic pathways and targets that are currently being explored for its treatment.

1.00 CE Credit(s)
Expires: April 29, 2023

Target Audience

This activity is intended for allergy/immunology physicians, NPs, and PAs who manage patients with EoE.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Identify patients with eosinophilic esophagitis (EoE) early by applying guideline-based diagnostic approaches
  • Assess the potential benefits and disadvantages of contemporary management strategies for patients with EoE
  • Summarize the role of type 2-mediated immune reactivity in the development of EoE and its implication for treatment
  • Analyze available data on therapies targeting type 2 immune reactivity for the treatment of patients with EoE

Activity Faculty


Matthew Greenhawt, MD, MBA, MSc (Chair)

Professor, Pediatrics
Director, Food Challenge and Research Unit
Section of Allergy and Immunology
Children’s Hospital Colorado
University of Colorado School of Medicine
Aurora, CO


Seema S. Aceves, MD, PhD

Professor, Pediatrics and Medicine
MRD Endowed Chair, Pediatrics
Director, Eosinophilic Gastrointestinal Disorders Clinic
Division of Allergy Immunology
Rady Children’s Hospital San Diego
University of California, San Diego
La Jolla, CA


Evan S. Dellon, MD, MPH

Professor, Medicine
Adjunct Professor, Epidemiology
University of North Carolina School of Medicine
Chapel Hill, NC

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources